A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT01957059 · TERMINATED
Trial details
- NCT number
- NCT01957059
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-08-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.